Status: Recruiting
Aromatherapy Inhaler Use for HSCT Distress
This randomized controlled trial will evaluate the feasibility and acceptability of an inhaled aromatherapy stick for patients during the acute inpatient phase after hematopoietic cell transplantation (HCT) . The study will also explore whether aromatherapy use is associated with short-term changes in patient-reported cancer-related distress and coping self-efficacy.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Stanford UniversityUpdated: Jun 2, 2026Locations: 1
Eligibility criteria
Autologous and Allogeneic patients admitted to E1 for planned HSCT [+6]
Patients admitted for Chimeric Antigen Receptor T cell (CART) infusion [+10]